Cavalier Jason
Lyra Therapeutics, Inc. · Principal Financial Officer
Cavalier Jason is listed in filings as Principal Financial Officer at Lyra Therapeutics, Inc.. This profile follows SEC Form 4 activity through Apr 3, 2026, including sale activity. Recent filings connect the profile to Lyra Therapeutics, Inc. (LYRA). The current snapshot covers public activity from Oct 18, 2024 to Apr 3, 2026. Reported amounts are shown as $2.6K to $6.1K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $2.6k769 shares | SellJan 6, 2026 | $3.36 | $0.52 |